ALBT Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: April 01, 2026
Report Source: 2025 Annual Report
Avalon Globocare Corp. Stock Analysis ALBT
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. The company is headquartered in Freehold, New Jersey and currently employs 2 full-time employees. The company went IPO on 2016-02-22. The firm operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The firm is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.
Read More Avalon Globocare Corp (ALBT) Chart
Key Statistics of Avalon Globocare Corp (ALBT)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.34Volume
59.18KP/E Ratio (TTM)
-52 Week Range
Market Cap
3.50MAvg. Volume
1.70MDividend Yield
-Financial Metrics & Statements of Avalon Globocare Corp (ALBT)
FAQ's for Avalon Globocare Corp (ALBT)
- According to Musaffa’s Shariah screening methodology, Avalon Globocare Corp (ALBT) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.